Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography

Journal of Proteome Research

Volumn 9, Issue 10, 2010, Pages 5239-5249

  Gordon, Scott M ^a   Deng, Jingyuan ^b   Lu, L Jason ^b   Davidson, W Sean ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

apolipoprotein; high density lipoprotein; lipoprotein; mass spectrometry; proteomics

Indexed keywords

CALCIUM SILICATE; HIGH DENSITY LIPOPROTEIN; LIPID BINDING PROTEIN; PHOSPHOLIPID BINDING RESIN; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; ELECTROSPRAY MASS SPECTROMETRY; ENZYME INHIBITION; GEL FILTRATION CHROMATOGRAPHY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEOMICS;

ADULT; CENTRIFUGATION, DENSITY GRADIENT; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, GEL; HUMANS; LIPOPROTEINS, HDL; MALE; PARTICLE SIZE; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; YOUNG ADULT;

EID: 77957340934     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100520x     Document Type: Article

References (39)

1. Scanu, A. M.; Wisdom, C. Serum lipoproteins structure and function Annu. Rev. Biochem. 1972, 41, 703-730
2. Franceschini, G.; Maderna, P.; Sirtori, C. R. Reverse cholesterol transport: physiology and pharmacology Atherosclerosis 1991, 88 (2-3) 99-107
3. Gordon, T.; Castelli, W. P.; Hjortland, M. C.; Kannel, W. B.; Dawber, T. R. High density lipoprotein as a protective factor against coronary heart disease Am. J. Med. 1977, 62 (5) 707-714
4. Gordon, D. J.; Probstfield, J. L.; Garrison, R. J.; Neaton, J. D.; Castelli, W. P.; Knoke, J. D.; Jacobs, D. R., Jr.; Bangdiwala, S.; Tyroler, H. A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 1989, 79 (1) 8-15
5. Mackness, M. I.; Arrol, S.; Durrington, P. N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein FEBS Lett. 1991, 286 (1-2) 152-154
6. Cockerill, G. W.; Rye, K. A.; Gamble, J. R.; Vadas, M. A.; Barter, P. J. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules Arterioscler., Thromb. Vasc. Biol. 1995, 15 (11) 1987-1994
7. Tolle, M.; Pawlak, A.; Schuchardt, M.; Kawamura, A.; Tietge, U. J.; Lorkowski, S.; Keul, P.; Assmann, G.; Chun, J.; Levkau, B.; van der Giet, M.; Nofer, J. R. HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production Arterioscler., Thromb. Vasc. Biol. 2008, 28 (8) 1542-1548
8. Davidsson, P.; Hulthe, J.; Fagerberg, B.; Camejo, G. Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins Arterioscler., Thromb. Vasc. Biol. 2010, 30 (2) 156-163
9. Shih, D. M.; Gu, L.; Xia, Y. R.; Navab, M.; Li, W. F.; Hama, S.; Castellani, L. W.; Furlong, C. E.; Costa, L. G.; Fogelman, A. M.; Lusis, A. J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Nature 1998, 394 (6690) 284-287
10. Hoff, H. F.; ONeil, J.; Chisolm, G. M., III; Cole, T. B.; Quehenberger, O.; Esterbauer, H.; Jurgens, G. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages Arteriosclerosis 1989, 9 (4) 538-549
11. Shao, B.; Oda, M. N.; Vaisar, T.; Oram, J. F.; Heinecke, J. W. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease Curr. Opin. Mol. Ther. 2006, 8 (3) 198-205
12. Gordon, S.; Durairaj, A.; Lu, J.; Davidson, W. S. High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality. Current Cardiovascular Risk Reports 4[Volume 4, Number 1]. 1-5-2010. Current Medicine Group LLC.
13. Vaisar, T.; Pennathur, S.; Green, P. S.; Gharib, S. A.; Hoofnagle, A. N.; Cheung, M. C.; Byun, J.; Vuletic, S.; Kassim, S.; Singh, P.; Chea, H.; Knopp, R. H.; Brunzell, J.; Geary, R.; Chait, A.; Zhao, X. Q.; Elkon, K.; Marcovina, S.; Ridker, P.; Oram, J. F.; Heinecke, J. W. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL J. Clin. Invest 2007, 117 (3) 746-756
14. vant, H. F.; Havel, R. J. Metabolism of apolipoprotein E in plasma high density lipoproteins from normal and cholesterol-fed rats J. Biol. Chem. 1982, 257 (18) 10996-11001
15. Cham, B. E.; Knowles, B. R. A solvent system for delipidation of plasma or serum without protein precipitation J. Lipid Res. 1976, 17 (2) 176-181
16. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-5392
17. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-4658
18. Davidson, W. S.; Silva, R. A.; Chantepie, S.; Lagor, W. R.; Chapman, M. J.; Kontush, A. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function Arterioscler., Thromb. Vasc. Biol. 2009, 29 (6) 870-876
19. Usui, S.; Hara, Y.; Hosaki, S.; Okazaki, M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC J. Lipid Res. 2002, 43 (5) 805-814
20. An Trinh. LRA (Lipid Removal Agent): Synthetic calcium silicate hydrate for the selective removal of lipids, endotoxins and other bio-organic molecules. Sigma-Aldrich Catalogue, 2010.
21. Havel, R. J.; EDER, H. A.; BRAGDON, J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J. Clin. Invest. 1955, 34 (9) 1345-1353
22. Collins, L. A.; Mirza, S. P.; Kissebah, A. H.; Olivier, M. An integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry. Physiol. Genomics 2010, 40 ((3)) 208 - 215.
23. Tenner, A. J. Functional aspects of the C1q receptors Behring Inst. Mitt. 1993, 93) 241-253
24. Matsushita, M.; Endo, Y.; Hamasaki, N.; Fujita, T. Activation of the lectin complement pathway by ficolins Int. Immunopharmacol. 2001, 1 (3) 359-363 (Pubitemid 32197536)
25. Cuchel, M.; Rader, D. J. The role of high density lipoproteins in thrombosis Sci. World J. 2002, 2, 89-95
26. Heller, M.; Stalder, D.; Schlappritzi, E.; Hayn, G.; Matter, U.; Haeberli, A. Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins Proteomics 2005, 5 (10) 2619-2630
27. Karlsson, H.; Leanderson, P.; Tagesson, C.; Lindahl, M. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry Proteomics 2005, 5 (5) 1431-1445
28. Han, Y. P.; Yan, C.; Garner, W. L. Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1- antichymotrypsin J. Invest Dermatol. 2008, 128 (9) 2334-2342
29. Plotnick, M. I.; Rubin, H.; Schechter, N. M. The effects of reactive site location on the inhibitory properties of the serpin alpha(1)-antichymotrypsin J. Biol. Chem. 2002, 277 (33) 29927-29935
30. Becerra, S. P.; Sagasti, A.; Spinella, P.; Notario, V. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop J. Biol. Chem. 1995, 270 (43) 25992-25999
31. Houenou, L. J.; DCosta, A. P.; Li, L.; Turgeon, V. L.; Enyadike, C.; Alberdi, E.; Becerra, S. P. Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons J. Comp. Neurol. 1999, 412 (3) 506-514
32. Crowe, S.; Wu, L. E.; Economou, C.; Turpin, S. M.; Matzaris, M.; Hoehn, K. L.; Hevener, A. L.; James, D. E.; Duh, E. J.; Watt, M. J. Pigment epithelium-derived factor contributes to insulin resistance in obesity Cell Metab. 2009, 10 (1) 40-47
33. Wewer, U. M.; Ibaraki, K.; Schjorring, P.; Durkin, M. E.; Young, M. F.; Albrechtsen, R. A potential role for tetranectin in mineralization during osteogenesis J. Cell Biol. 1994, 127 (6 Pt 1) 1767-1775
34. Quantock, A. J.; Meek, K. M.; Chakravarti, S. An x-ray diffraction investigation of corneal structure in lumican-deficient mice Invest. Ophthalmol. Vis. Sci. 2001, 42 (8) 1750-1756
35. Ezura, Y.; Chakravarti, S.; Oldberg, A.; Chervoneva, I.; Birk, D. E. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons J. Cell Biol. 2000, 151 (4) 779-788
36. Twigg, S. M.; Kiefer, M. C.; Zapf, J.; Baxter, R. C. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain J. Biol. Chem. 1998, 273 (44) 28791-28798
37. Domene, H. M.; Hwa, V.; Argente, J.; Wit, J. M.; Camacho-Hubner, C.; Jasper, H. G.; Pozo, J.; van Duyvenvoorde, H. A.; Yakar, S.; Fofanova-Gambetti, O. V.; Rosenfeld, R. G. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences Horm. Res. 2009, 72 (3) 129-141
38. Thomson, R.; Samanovic, M.; Raper, J. Activity of trypanosome lytic factor: a novel component of innate immunity Future Microbiol. 2009, 4, 789-796
39. Keshava Prasad, T. S.; Goel, R.; Kandasamy, K. Human Protein Reference Database - 2009 update Nucleic Acids Res. 2009, 37 (Database issue) D767-D772